EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
EQHA.WS was delisted on the 25th of November, 2022.
1 hedge funds and large institutions have $58 invested in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 63 closing their positions.
98% less funds holding
Funds holding: 63 → 1 (-62)
98% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 63
100% less capital invested
Capital invested by funds: $5.58M → $58 (-$5.57M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AS
Altshuler Shaham
Tel Aviv,
Israel
|
+$5.34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$2.22M |
| 2 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$1.64M |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
-$494K |
| 4 |
SCM
Segantii Capital Management
Hong Kong
|
-$494K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$162K |
EQHA.WS Hedge Fund Activity: Q4 2022 in Review
1 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) for Q4 2022, worth a combined $58 — down 100% from $5.58M a quarter earlier.
Sellers outnumbered buyers: 63 funds closed out of EQHA.WS and 1 opened new positions — a net loss of 62 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Altshuler Shaham, opening a new position worth an estimated $5.34K. The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $2.22M sold.
- 1 institutional investor held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) as of Q4 2022, down from 63 in Q3 2022.
- Funds reported $58 of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q4 2022, down 100% quarter-over-quarter.
- 1 fund opened new EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q4 2022 and 63 closed out, a net change of -62 holders.
- The largest EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q4 2022 was Altshuler Shaham, an estimated $5.34K added.
- The largest EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q4 2022 was Radcliffe Capital Management, an estimated $2.22M sold.
Based on aggregated 13F filings for Q4 2022.